Clobetasol Propionate Ophthalmic Nanoemulsion 0.05%
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Clobetasol Propionate Ophthalmic Nanoemulsion 0.05%, covering 2022-12-22 to 2024-09-27. Get the full timeline:
Most recent: Clinical Trial Update: Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population [Phase 3]